RECCHIA, FABIO ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 22.746
EU - Europa 13.652
AS - Asia 9.295
SA - Sud America 1.540
AF - Africa 186
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 43
AN - Antartide 1
Totale 47.550
Nazione #
US - Stati Uniti d'America 22.057
SG - Singapore 3.458
GB - Regno Unito 3.415
RU - Federazione Russa 2.677
CN - Cina 2.480
IT - Italia 2.218
UA - Ucraina 1.299
VN - Vietnam 1.251
BR - Brasile 1.243
DK - Danimarca 1.118
DE - Germania 1.106
HK - Hong Kong 815
CA - Canada 516
BD - Bangladesh 462
SE - Svezia 455
FR - Francia 394
FI - Finlandia 308
IE - Irlanda 203
IN - India 181
MX - Messico 115
PL - Polonia 110
AR - Argentina 104
JP - Giappone 93
NL - Olanda 93
EU - Europa 84
ID - Indonesia 77
IQ - Iraq 76
ZA - Sudafrica 66
ES - Italia 63
TR - Turchia 61
EC - Ecuador 55
IL - Israele 51
PK - Pakistan 48
VE - Venezuela 38
CO - Colombia 37
AU - Australia 33
CH - Svizzera 32
UZ - Uzbekistan 31
SA - Arabia Saudita 28
AT - Austria 26
CL - Cile 26
MA - Marocco 24
PH - Filippine 24
LT - Lituania 23
KR - Corea 18
MY - Malesia 18
AE - Emirati Arabi Uniti 17
PT - Portogallo 17
PY - Paraguay 17
RO - Romania 17
TH - Thailandia 15
BE - Belgio 14
EG - Egitto 14
KE - Kenya 14
TN - Tunisia 14
RS - Serbia 12
AZ - Azerbaigian 11
UY - Uruguay 11
CR - Costa Rica 10
DZ - Algeria 10
JO - Giordania 10
KZ - Kazakistan 10
JM - Giamaica 9
NP - Nepal 9
NZ - Nuova Zelanda 9
HU - Ungheria 8
IR - Iran 8
SN - Senegal 8
CZ - Repubblica Ceca 7
TT - Trinidad e Tobago 7
ET - Etiopia 6
HN - Honduras 6
KG - Kirghizistan 6
NG - Nigeria 6
AL - Albania 5
AO - Angola 5
CI - Costa d'Avorio 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
GE - Georgia 4
KW - Kuwait 4
LB - Libano 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
PS - Palestinian Territory 4
SV - El Salvador 4
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GT - Guatemala 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BS - Bahamas 2
BY - Bielorussia 2
GA - Gabon 2
GR - Grecia 2
Totale 47.505
Città #
Dallas 2.974
Southend 2.638
Woodbridge 1.900
Ann Arbor 1.698
Singapore 1.557
San Jose 1.335
Chandler 1.253
Houston 1.160
Ashburn 1.035
Beijing 996
Fairfield 793
San Mateo 790
Hong Kong 699
Dearborn 657
Jacksonville 635
Moscow 467
Seattle 462
Falls Church 455
The Dalles 448
Wilmington 393
Milan 390
Cambridge 385
Wayne 330
Los Angeles 309
Ho Chi Minh City 288
Boardman 263
Dong Ket 255
Stevenage 252
Hefei 224
Rome 220
Portsmouth 219
Lauterbourg 215
Pisa 212
Lawrence 209
New York 193
Hanoi 192
Dublin 182
Chicago 159
Santa Clara 139
Brooklyn 136
Ottawa 123
Beauharnois 121
São Paulo 121
Redwood City 118
Council Bluffs 115
Buffalo 102
Warsaw 97
Montréal 91
Guangzhou 87
Helsinki 86
Columbus 79
Tokyo 78
Orem 72
San Diego 71
Munich 70
Old Bridge 69
London 68
Figino 61
Montreal 56
Mexico City 53
Salt Lake City 51
Tel Aviv 46
Johannesburg 45
Phoenix 42
Stockholm 42
Norwalk 41
Chennai 40
Florence 39
Denver 38
Rio de Janeiro 38
Haiphong 36
Atlanta 35
Baghdad 35
San Francisco 35
Turin 35
Da Nang 33
Manchester 33
Elk Grove Village 31
Toronto 31
Frankfurt am Main 29
Miami 29
Paris 29
Tashkent 29
Poplar 28
Naples 27
Amsterdam 25
Belo Horizonte 25
Boston 25
Curitiba 25
Brasília 23
Dhaka 23
Turku 23
Cascina 22
Mumbai 22
Fremont 21
Lahore 21
New Delhi 20
Tampa 20
Bologna 19
Istanbul 19
Totale 30.085
Nome #
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction 607
Enabling MSI-Guided Laser Capture Microdissection 448
3D CMR Mapping of Metabolism by Hyperpolarized 13C-Pyruvate in Ischemia–Reperfusion 422
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. 422
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis 407
Surgical Access and Stimulation of the Pig Pudendal Nerve to Restore Bladder Dysfunctions 402
A Dose-Response Elevation in Hepatic Glucose Uptake is Paralleled by Liver Triglyceride Synthesis and Release. 387
Cardiac adeno-associated virus 9-mediated delivery of nestin-640 prevents myocardial remodeling in a rodent model of post-ischemic heart failure 359
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 355
Acetylation mediates Cx43 reduction caused by electrical stimulation 350
AAV-Mediated Delivery of VEGF-B Preserves Viability and Cardiac Function Following Myocardial Infarction through a Direct Effect on Cardiomyocyte Survival and Contractility 334
Molecular Advances in Reporter Genes: The Need to Witness the Function of Stem Cells in Failing Heart in Vivo. 330
A partial knockdown of glucose-6-phosphate dehydrogenase impairs cardiac contractile performance and efficiency, in vivo 330
REGIONAL MAPPING OF MYOCARDIAL HIBERNATION PHENOTYPE IN IDIOPATHIC END-STAGE DILATED CARDIOMYOPATHY 330
An Implantable ZigBee Ready Telemetric Platform For In Vivo Monitoring Of Physiological Parameters 328
A software tool for the real-time in vivo evaluation of neural electrodes' selectivity 324
Acute vagal stimulation attenuates cardiac metabolic response to beta-adrenergic stress. 322
A lightweight learning-based decoding algorithm for intraneural vagus nerve activity classification in pigs 318
Myocardial substrate metabolism in the normal and failing heart 313
Adaptation and optimization of an intraneural electrode to interface with the cervical vagus nerve 312
Neural stimulation hardware for the selective intrafascicular modulation of the vagus nerve 302
Placental stem cells pre-treated with hyaluronan-butyric-retinoic ester to cure infarcted pig hearts: a multimodal study. 302
Gene Therapy for Heart Failure: New Perspectives 302
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure 298
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. 294
A fast and accurate learning-based decoding algorithm for the classification of cardiovascular and respiratory challenges using intraneural electrodes in the pig vagus nerve 293
Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure 293
Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else? 293
Real time cardiac metabolism assessed with hyperpolarized [1-13C] acetate in a large animal model 289
Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms 288
Acute NO synthase inhibition increases the activities of myocardial glyceraldehyde-3-phosphate-dehydrogenase and malonyl-CoA-decarboxylase in conscious dogs. 285
Abnormal stress-induced myocardial metabolic changes in patients with dilated cardiomyopathy. 283
Acute NO synthase inhibition profoundly alters myocardial oxidation of free fatty acids and glucose in conscious dogs 282
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. 281
Q-PINE: A quick to implant peripheral intraneural electrode 281
Multimodal molecular imaging system for pathway-specific reporter gene expression 280
Acute and chronic endothelial dysfunction: implications for the development of heart failure. 277
ACE-inhibitor, modulates myocardial glucose uptake via B2-kinin receptor-mediated cardiac NO production in Langendorff mouse heart. 271
A novel endothelial mechanism that counteracts arteriolar constriction. 270
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. 264
Mass Spectrometry Imaging as a Tool to Investigate Region Specific Lipid Alterations in Symptomatic Human Carotid Atherosclerotic Plaques 264
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 262
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. 259
Low HDL - high inflammatory markers in heart failure induced by high frequency pacing in minipigs. 258
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction 258
Modulating Fatty Acid Oxidation in Heart Failure 257
Adaptive induction of NF-E2–Related Factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia 254
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture 254
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. 252
Glucose-6-Phosphate Dehydrogenase Deficiency Increases Myocardial Redox Stress and Moderately Accelerates the Development of Heart Failure 252
Intracoronary gene delivery of the cytoprotective factor vascular endothelial growth factor-B167 in canine patients with dilated cardiomyopathy: A short-term feasibility study 250
DNP methods for cardiac metabolic imaging with hyperpolarized [1-13C]pyruvate large dose injection in pigs 249
Acute Vagal Stimulation Attenuates Cardiac Metabolic Response to Beta-adrenergic Stress in Chronically Instrumented Dogs. 249
Cardiovascular Molecular Imaging with Hyperpolarized [1-13C] acetate and [1-13C] pyruvate in middle size animal model 245
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure 243
Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. 242
LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGS 242
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy 240
Animal models of dilated cardiomyopathy for translational research. 239
Reduced cardiac NO production during pacing-induced heart failure 238
Early mechanical dyssynchrony induced by unipolar left ventricular pacing is unrelated to myocardial flow and metabolism 237
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. 236
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs 235
Transthoracic Sensor for Noninvasive Assessment of Left Ventricular Contractility: Validation in A Minipig Model of Chronic Heart Failure. 234
Overview of ventilator-induced lung injury mechanisms 234
Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. 234
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 233
Early detection of acute lung injury uncoupled to hypoxemia in pigs using ultrasound lung comets. 233
Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs 229
Stem cells transduction with ferritin as a reporter gene to track their fate by 1.5 Tesla MRI, in the beating heart. 228
Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. 226
Nitric oxide-mediated arteriolar dilation after endothelial deformation 225
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. 225
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. 225
Nestin is a key regulator of cardioprotection and nestin-640 gene therapy rescues infarcted myocardium 225
Closed-Loop Vagus Nerve Stimulation for the Treatment of Cardiovascular Diseases: State of the Art and Future Directions 224
Post-mortem CMR in a model of sudden death due to myocardial ischemia: validation with connexin-43 224
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. 224
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. 224
Chronic inhibition of nitric oxide synthase alters cardiac substrate handling: underestimating changes in metabolism. 224
Pathologic pulse pressure in isolated coronary artery bed augments flow in vivo despite constant ventricular workload 223
In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells 222
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. 222
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 222
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy 222
Calculation of the protein turnover rate using the number of incorporated 2H atoms and proteomics analysis of a single labeled sample 222
Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs. 221
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. 220
Diverse protein kinase A-dependent myofilament protein phosphorylation in the background of regional contractile dysfunction in pacing-induced heart failure 220
Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. 219
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. 217
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. 217
Short Interfering RNA-Mediated Knockdown Of Glucose-6-Phosphate Dehydrogenase Impairs Cardiac Contractile Performance and Efficiency in Conscious Dogs. 216
Changes in cardiac metabolism produced by acute inhibition of NO synthase can be reversed by a long-acting NO donor 216
Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats 216
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense 216
Pre-treatment of human mesenchymal stem cells with a chemical inductor of cardiogenesis increases their effects on regional myocardial function in a swine model of myocardial infarction. 213
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. 212
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications 212
Amlodipine releases nitric oxide (NO) from coronary microvessels after pacing induced dilated cardiomyopathy. 212
Totale 27.074
Categoria #
all - tutte 228.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 228.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021614 0 0 0 0 0 0 0 0 0 0 0 614
2021/20223.340 170 615 419 278 65 61 315 592 162 323 81 259
2022/20232.877 233 126 48 605 366 469 36 235 481 69 110 99
2023/20241.082 151 66 203 58 65 161 133 31 13 36 42 123
2024/20256.768 79 62 419 238 188 514 1.027 1.928 553 220 771 769
2025/202616.939 782 2.774 1.619 1.694 1.664 968 2.421 782 1.079 1.258 874 1.024
Totale 47.737